FrancophonIA/ELRC3.0 huggingface dataset:
English: You may be allergic to immunoglobulins without knowing it. Allergic reactions such as sudden fall in blood pressure or anaphylactic shock (a sharp fall in blood pressure with other symptoms such as swelling of the throat, breathing difficulties and skin rash) are rare but they can occasionally occur even if you have not previously had problems with similar treatments.
Slovenian: Alergijske reakcije, kot so nenaden padec krvnega tlaka ali anafilaktični šok (nenaden padec krvnega tlaka z drugimi simptomi, kot so otekanje žrela, oteženo dihanje in kožni izpuščaj), so redke, vendar do njih lahko pride tudi, če prej niste imeli težav s podobnim zdravljenjem.
English: Each vial of IG 10% is supplied with the appropriate corresponding quantity of recombinant human hyaluronidase as stated in the table below.
Slovenian: Vsaka viala IG 10 % je na voljo z ustrezno količino rekombinantne humane hialuronidaze, kot je navedeno v spodnji preglednici.
English: Do not inject or infuse HyQvia
Slovenian: Ne injicirajte ali infundirajte zdravila HyQvia:
English: The effects of antibodies to the recombinant human hyaluronidase component of HyQvia on the human embryo or on human foetal development are currently unknown (see section 5.3).
Slovenian: Učinki protiteles proti komponenti z rekombinantno hialuronidazo zdravila HyQvia na človeški zarodek ali razvoj človeškega plodu trenutno še niso znani (glejte poglavje 5.3).
English: These antibodies bind to red blood cells (RBC) epitops (which may be detected as a positive direct antiglobulin test [DAT, (Coombs' test)] and, rarely, may cause haemolysis.
Slovenian: Ta protitelesa se vežejo na epitope eritrocitov (kar lahko zaznamo kot pozitivni neposredni protiglobulinski test [direct antiglobulin test, DAT (Coombsov test)]) in v redkih primerih lahko povzročajo hemolizo.
English: Immunoglobulins are normal constituents of the human body.
Slovenian: Imunoglobulini so normalne sestavine v človeškem telesu.
English: The dosage interval to maintain steady state levels varies from 2-4 weeks.
Slovenian: Presledek med odmerki za ohranjanje koncentracije v stanju dinamičnega ravnovesja je od 2 do 4 tedne.
English: • Official batch release
Slovenian: • Uradna sprostitev serije:
English: Patients previously treated with immunoglobulin administered subcutaneously For patients currently being administered immunoglobulin subcutaneously, the initial dose of HyQvia is the same as for subcutaneous treatment, but may be adjusted to 3- or 4-weeks interval.
Slovenian: Bolniki, ki so bili predhodno zdravljeni z imunoglobulini, uporabljenimi subkutano Pri bolnikih, ki trenutno prejemajo imunoglobuline subkutano, je začetni odmerek zdravila HyQvia enak kot za subkutano zdravljenje, vendar se lahko prilagodi na tri-ali štiritedenski presledek.
English: HyQvia contains two solutions for infusion (drip) under the skin (subcutaneous or SC infusion).
Slovenian: Zdravilo HyQvia vsebuje dve raztopini za infundiranje (kapalno infuzijo) pod kožo (subkutana ali s.c. infuzija).
English: At the initiation of therapy, it is recommended that the treatment intervals for the first infusions be gradually prolonged from a 1-week dose to up to a 3- or 4-week dose.
Slovenian: Priporočljivo je, da ob začetku zdravljenja presledke med prvimi infundiranji postopno podaljšujete od enotedenskega odmerka do tri-ali štiritedenskega odmerka.
English: 90.52 (83.8 to 9)
Slovenian: 90,52 (83,8 do 98,4)
English: If you think that you have missed a dose speak to your doctor as soon as possible.
Slovenian: Če menite, da ste pozabili odmerek, se čimprej posvetujte s svojim zdravnikom.
English: The cumulative monthly dose of IG 10% should be divided into 1-week, 2-week etc. doses according to the planned treatment intervals with HyQvia.
Slovenian: Kumulativni mesečni odmerek IG 10 % razdelite v enotedenske, dvotedenske itn. odmerke po načrtovanih presledkih med odmerki zdravila HyQvia.
English: Any suspicion of allergic or anaphylactic like reactions following recombinant human hyaluronidase administration requires immediate discontinuation of the infusion and standard medical treatment should be administered, if necessary.
Slovenian: Pri sumu na alergijsko ali anafilaktično reakcijo po infundiranju rekombinantne humane hialuronidaze je potrebna takojšnja ustavitev infundiranja in po potrebi uvedba standardnega medicinskega zdravljenja.
English: How HyQvia works
Slovenian: Kako zdravilo HyQvia deluje
English: Human normal immunoglobulin (SCIg)
Slovenian: Humani polispecifični imunoglobulin (SCIg)
English: Human normal immunoglobulin 10% belongs to a class of medicines called “human normal immunoglobulins”.
Slovenian: Humani polispecifični imunoglobulin 10 % spada v skupino zdravil, ki jim pravimo ”humani polispecifični imunoglobulini”.
English: Marketing Authorisation Holder: Baxalta Innovations GmbH Industriestrasse 67
Slovenian: Imetnik dovoljenja za promet: Baxalta Innovations GmbH Industriestrasse 67
English: The two components of the medicinal product must be administered sequentially through the same needle beginning with the recombinant human hyaluronidase followed by IG 10%, as described below.
Slovenian: Obe komponenti zdravila je treba dati zaporedno skozi isto iglo: najprej rekombinantno humano hialuronidazo, nato pa še IG 10 %, kakor je opisano v nadaljevanju.
English: After administration of this medicinal product, an interval of 3 months should elapse before vaccination with live attenuated virus vaccines.
Slovenian: Po dajanju tega zdravila morajo preteči 3 meseci, preden lahko bolnika cepite z živimi oslabljenimi virusnimi cepivi.
English: Patients should be informed about first symptoms of thromboembolic events including shortness of breath, pain and swelling of a limb, focal neurological deficits and chest pain and should be advised to contact their physician immediately upon onset of symptoms.
Slovenian: Bolnike je treba poučiti o prvih simptomih tromboemboličnih dogodkov, vključno z zasoplostjo, bolečinami v okončinah in otekanjem okončin, žariščnimi nevrološkimi deficiti in bolečinami v prsnem košu, ter jim naročiti, da se ob pojavu simptomov nemudoma posvetujejo s svojim zdravnikom.
English: The recombinant human hyaluronidase of HyQvia acts locally.
Slovenian: Rekombinantna humana hialuronidaza v zdravilu HyQvia deluje lokalno.
English: HyQvia may reduce the effect of some virus vaccines such as measles, rubella, mumps and chicken pox (live virus vaccines).
Slovenian: Zdravilo HyQvia lahko zmanjša učinkovitost nekaterih virusnih cepiv, kot so cepiva proti ošpicam, rdečkam, mumpsu in noricam (živa virusna cepiva).
English: • Hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic leukaemia (CLL), in whom prophylactic antibiotics have failed or are contra-indicated.
Slovenian: • hipogamaglobulinemiji in ponavljajočih se bakterijskih okužbah pri bolnikih s kronično limfocitno levkemijo (KLL), pri katerih je bilo profilaktično zdravljenje z antibiotiki neuspešno ali je kontraindicirano,
English: In case of shock, immediately discontinue the infusion and treat the patient for shock.
Slovenian: V primeru šoka je treba takoj prekiniti infundiranje in začeti standardno zdravljenje za šok.
English: In case subcutaneous infusion of HyQvia is used for home treatment, therapy should be initiated and monitored by a physician experienced in the guidance of patients for home treatment.
Slovenian: Subkutano infundiranje zdravila HyQvia pri zdravljenju doma naj uvede in spremlja zdravnik z izkušnjami v vodenju bolnikov pri zdravljenju na domu.
English: Adequate doses of human normal immunoglobulin may restore abnormally low IgG levels to the normal range.
Slovenian: Z ustreznimi odmerki polispecifičnega imunoglobulina lahko obnovimo nenormalno nizko koncentracijo IgG do normalnega razpona.
English: From post-marketing data no clear correlation of AMS to higher doses was observed.
Slovenian: Podatki iz obdobja trženja ne kažejo jasne povezave AMS z velikimi odmerki.
English: 93.9 (89.1 to 102.1)
Slovenian: 93,9 (89,1 do 102,1)
English: Immunoglobulins are excreted into the milk and may contribute to protecting the neonate from pathogens which have a mucosal portal of entry.
Slovenian: Imunoglobulini se izločajo v materino mleko in lahko prispevajo k zaščiti novorojenčka pred patogeni, ki vstopajo prek sluznic.
English: The IG 10% component contains trace amounts of sodium.
Slovenian: Komponenta IG 10 % vsebuje natrij v sledovih.
English: Subsequent 2 to 3 Infusions (ml/hour/infusion site)
Slovenian: Naslednje 2−3 infuzije (ml/uro/mesto infundiranja)
English: However, needles with smaller diameters may be used if slower flow rates are acceptable.
Slovenian: Če je sprejemljiva manjša hitrost infundiranja, se lahko uporabijo igle z manjšimi premeri.
English: Sodium chloride, sodium phosphate, human albumin, ethylenediaminetetraacetic acid disodium, calcium chloride, water for injections.
Slovenian: Natrijev klorid, natrijev fosfat, humani albumin, dinatrijev etilendiamintetraacetat, kalcijev klorid, voda za injekcije.
English: Acute renal failure
Slovenian: Akutna ledvična odpoved
English: The following dosage regimens are given as a guideline.
Slovenian: V nadaljevanju so navedene priporočene sheme odmerjanja.
English: Nearly all of the subjects were able to attain the same dose interval with HyQvia as they had for intravenous administration.
Slovenian: Pri skoraj vseh preiskovancih je bilo možno doseči enak presledek odmerjanja zdravila HyQvia kot pri intravenskem dajanju.
English: The patient will be instructed in infusion techniques, the use of an infusion pump or syringe driver, the keeping of a treatment diary, recognition of possible severe adverse reactions and measures to be taken in case these occur.
Slovenian: Bolnika je treba poučiti o tehnikah infundiranja, uporabi infuzijske črpalke ali pripomočka, vodenju dnevnika zdravljenja, prepoznavanju morebitnih hudih neželenih učinkov in ukrepih ob pojavu teh učinkov.
English: Replacement therapy should be initiated and monitored under the supervision of a physician experienced in the treatment of immunodeficiency.
Slovenian: Nadomestno zdravljenje mora uvesti in spremljati zdravnik, ki ima izkušnje z zdravljenjem imunskih pomanjkljivosti.
English: • Throw away any unused product in the vial and the disposable supplies as recommended by your healthcare professional.
Slovenian: • Neuporabljeno zdravilo v viali ter pripomočke za enkratno uporabo zavrzite po navodilu zdravstvenega delavca.
English: Human normal immunoglobulin (IG 10%) vial 25, 50, 100, 200 or 300 ml of solution in a vial (Type I glass) with a stopper (bromobutyl rubber).
Slovenian: Viala humanega polispecifičnega imunoglobulina (IG 10 %) 25, 50, 100, 200 ali 300 ml raztopine v viali (iz stekla tipa I) z zamaškom (iz bromobutilne gume).
English: Do not infuse HyQvia into or around an infected or red swollen area on your skin because it may cause the infection to spread.
Slovenian: Zdravila HyQvia ne infundirajte v okuženo oz. rdeče, oteklo področje kože ali v njegovo bližino zaradi nevarnosti širjenja okužbe.
English: Trough levels should be measured and assessed in conjunction with the incidence of infection.
Slovenian: Meriti morate najnižje koncentracije zdravila v krvi in jih vrednotiti skupaj s pojavnostjo okužb.
English: Human normal immunoglobulin and human serum albumin (stabilizer of the recombinant human hyaluronidase) are produced from human plasma.
Slovenian: Humani polispecifični imunoglobulin in humani serumski albumin (stabilizator rekombinantne humane hialuronidaze) sta pripravljena iz človeške plazme.
English: • If using a pump, prepare the pump to infuse the recombinant human hyaluronidase at an initial rate per infusion site of 60 to 120 ml/hour and increase as tolerated.
Slovenian: • Če uporabljate črpalko, jo pripravite tako, da infundira rekombinantno humano hialuronidazo z začetno hitrostjo na mesto infundiranja približno 60 do 120 ml/uro, ki jo povečujte, kolikor jo lahko prenašate.
English: When medicines are made from human blood or plasma, certain measures are put in place to prevent infections being passed on to patients.
Slovenian: Kadar se zdravila pripravljajo iz človeške krvi ali plazme, se z določenimi postopki preprečuje prenos okužb na bolnike.
English: You will be instructed in: - Germ-free (aseptic) infusion techniques, - The use of an infusion pump or syringe driver (if needed), - Keeping a treatment diary, and - Measures to be taken in case of severe side effects.
Slovenian: Poučili vas bodo o: - (aseptičnih) tehnikah infundiranja, ki preprečujejo vdor bolezenskim povzročiteljem, - uporabi infuzijske črpalke ali pripomočka za injiciranje (če sta potrebna), - vodenju dnevnika zdravljenja in - ukrepih v primeru, da nastopijo hudi neželeni učinki.
English: • Hypogammaglobulinaemia in patients pre- and post-allogeneic hematopoietic stem cell transplantation (HSCT).
Slovenian: • hipogamaglobulinemiji pri bolnikih pred alogensko presaditvijo krvotvornih matičnih celic (HSCT) in po njej.
English: 45.3 (41.0 to 60.2)
Slovenian: 45,3 (41,0 do 60,2)
English: Administer the human normal immunoglobulin 10%: After infusing all of the content of the smaller syringe (recombinant human hyaluronidase), remove the syringe from the hub of the needle set.
Slovenian: Infundirajte humani polispecifični imunoglobulin 10 %: Po infuziji celotne vsebine manjše brizge (rekombinantne humane hialuronidaze), izvlecite brizgo iz priključka kompleta injekcijske igle.
English: • Remove the peel-off label from HyQvia vial, which has the product lot number and expiration date, and place the label in your treatment record/log book.
Slovenian: • Odlepite nalepko z viale zdravila HyQvia, na kateri je navedena serija zdravila in datum izteka roka uporabnosti, ter jo nalepite v dnevnik zdravljenja.
English: • Patients should be informed of the early signs of anaphylaxis/hypersensitivity (hives, pruritus, generalized urticaria, tightness of the chest, wheezing, and hypotension).
Slovenian: • Bolnike morate poučiti o zgodnjih znakih anafilaksije/preobčutljivosti (koprivnica, srbenje, generalizirana urtikarija, tiščanje v prsih, sopenje in hipotenzija).
English: ► If you experience any side effects, you or your guardian must stop the infusion immediately and contact a doctor.
Slovenian: ► Če se neželeni učinki pojavijo, morate vi ali vaš skrbnik nemudoma prekiniti infundiranje in poklicati zdravnika.
English: Pack size: One vial of IG 10% and one vial of recombinant human hyaluronidase in a dual vial unit.
Slovenian: Velikost pakiranja: Ena viala IG 10 % in ena viala rekombinantne humane hialuronidaze v enoti z dvema vialama.
English: In the clinical study with HyQvia, no differences in the plasma IgG trough levels were observed between adult and paediatric patients.
Slovenian: V klinični študiji zdravila HyQvia niso ugotovili razlik v najnižjih plazemskih koncentracijah IgG med pediatričnimi bolniki in odraslimi bolniki.
English: • patients with low antibody production prior and after transplantation of bone marrow cells from another person.
Slovenian: • bolniki z nizko tvorbo protiteles pred presaditvijo celic kostnega mozga druge osebe in po presaditvi.
English: Despite these measures, when medicines prepared from human blood or plasma are used, the possibility of passing on infection cannot be totally excluded.
Slovenian: Kljub tem ukrepom pri uporabi zdravil, pripravljenih iz človeške krvi ali plazme, ni mogoče popolnoma izključiti prenosa okužbe.
English: Any long-term inflammation, lumps (nodules) or inflammation that occur at the infusion site and last more than a few days should be reported to your physician.
Slovenian: O vseh primerih dolgotrajnega vnetja, vozličev ali vnetja, ki se pojavi na mestu infundiranja in traja dlje kot nekaj dni, morate obvestiti zdravnika.
English: The suggested site(s) for the infusion of the medicinal product are the middle to upper abdomen and thighs.
Slovenian: Priporočena mesta infundiranje zdravila so srednji do zgornji del trebuha in stegna.
English: Patients must be closely monitored throughout the infusion period, particularly patients starting with therapy.
Slovenian: Bolnike, zlasti tiste, ki začenjajo zdravljenje, je treba natančno spremljati skozi ves čas trajanja infuzije.
English: Marketing Authorisation Holder and Manufacturer
Slovenian: Imetnik dovoljenja za promet z zdravilom in izdelovalci
English: 10.4 (9.4 to 11.2)
Slovenian: 10,4 (9,4 do 11,2)
English: The recombinant human hyaluronidase is a protein that makes it easier for the immunoglobulins to be infused (dripped) under the skin and to reach your blood system.
Slovenian: Rekombinantna humana hialuronidaza je beljakovina, ki imunoglobulinom, ki se infundirajo (s kapanjem) pod kožo, olajša prehod v krvni obtok.
English: Infuse the full dose per site of IG 10% through the same subcutaneous needle set within 10 minutes of the recombinant human hyaluronidase.
Slovenian: Celoten odmerek IG 10 % na mesto infundirajte skozi isti komplet igel v 10 minutah po opravljenem infundiranju rekombinantne humane hialuronidaze.
English: - if you are allergic to immunoglobulins, hyaluronidase, recombinant hyaluronidase or any of the other ingredients of this medicine (listed in section 6, “Contents of the pack and other information”).
Slovenian: - če ste alergični na imunoglobuline, hialuronidazo, rekombinantno hialuronidazo ali katero koli sestavino tega zdravila (navedeno v poglavju 6, ”Vsebina pakiranja in dodatne informacije”), - če imate v krvi protitelesa proti imunoglobulinu A (IgA), ki so lahko posledica pomanjkljivosti
English: What HyQvia looks like and contents of the pack
Slovenian: Izgled zdravila HyQvia in vsebina pakiranja
English: IG 10% is a clear or slightly opalescent and colourless or pale yellow solution.
Slovenian: IG 10 % je bistra ali rahlo opalescentna in brezbarvna ali bledo rumena raztopina.
English: • Do not shake.
Slovenian: • Ne stresajte.
English: In case of adverse reaction, either the rate of administration must be reduced or the infusion stopped.
Slovenian: V primeru neželenega učinka je treba zmanjšati hitrost dajanja ali prekiniti infundiranje.
English: Patients previously treated with immunoglobulin administered intravenously For patients switching directly from intravenous administration of immunoglobulin, or who have a previous intravenous dose of immunoglobulin that can be referenced, the medicinal product should be administered at the same dose and at the same frequency as their previous intravenous immunoglobulin treatment.
Slovenian: Bolniki, ki so bili predhodno zdravljeni z imunoglobulini, uporabljenimi intravensko Pri bolnikih, ki prehajajo neposredno z intravenske uporabe imunoglobulina ali so predhodno prejeli znan intravenski odmerek imunoglobulina, je treba zdravilo uporabiti v enakem odmerku in z enako pogostnostjo kakor prejšnje intravensko imunoglobulinsko zdravljenje.
English: No long-term (chronic) changes in the skin were observed in the clinical studies.
Slovenian: V kliničnih študijah niso opazili dolgotrajnih (kroničnih) sprememb kože.
English: HyQvia has to be infused under the skin (subcutaneous or SC administration).
Slovenian: Zdravilo HyQvia se infundira pod kožo (subkutano ali s.c. dajanje).
English: ► In such cases, you will be closely monitored during your first infusion and for the first hour after your infusion has stopped.
Slovenian: ► V takšnih primerih vas bodo med prvo infuzijo in v uri po končani infuziji natančno spremljali.
English: VIAL LABEL HUMAN NORMAL IMMUNOGLOBULIN (5 G, 10 G, 20 G AND 30 G)
Slovenian: NALEPKA NA VIALI HUMANEGA POLISPECIFIČNEGA IMUNOGLOBULINA (5 G, 10 G, 20 G IN 30 G)
English: Information on the source material of HyQvia
Slovenian: Informacije o izvornem materialu zdravila HyQvia
English: Prepare the infusion site:
Slovenian: Pripravite mesto infundiranja:
English: In these studies, maternal antibodies to recombinant human hyaluronidase were transferred to offspring in utero.
Slovenian: V teh študijah so se maternalna protitelesa proti rekombinantni humani hialuronidazi v maternici prenašala na potomce.
English: The recombinant human hyaluronidase of HyQvia contains small amounts (4.03 mg per ml) of sodium.
Slovenian: Rekombinantna humana hialuronidaza zdravila HyQvia vsebuje majhno količino natrija (4,03 mg na ml).
English: Passive transmission of antibodies to erythrocyte´s surface antigens, (e.g., A, B, D) may interfere with some serological tests for red cell antibodies for example the direct antiglobulin test (DAT, direct Coombs' test).
Slovenian: A, B in D) lahko moti nekatere serološke preiskave za protitelesa proti eritrocitom, npr. direktni antiglobulinski test (DAT, direktni Coombsov test).
English: Do not mix the components of HyQvia prior to administration.
Slovenian: Komponent zdravila HyQvia pred uporabo ne zmešajte.
English: You and your doctor will decide if you can use HyQvia at home. Do not begin treatment with HyQvia at home until you have received complete instructions.
Slovenian: Z zdravilom HyQvia se ne začnite zdraviti doma, dokler ne prejmete vseh navodil.
English: • Pull back on the plunger, fill the smaller syringe with air equal to the amount of recombinant human hyaluronidase in the HY vial(s).
Slovenian: • Povlecite bat in manjšo brizgo napolnite z zrakom do količine, ki je enaka količini rekombinantne humane hialuronidaze v viali (vialah) HY.
English: Do not use this medicine after the expiry date which is stated on the label and carton after EXP.
Slovenian: Tega zdravila ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na nalepki in škatli poleg oznake EXP. Datum izteka roka uporabnosti se nanaša na zadnji dan navedenega meseca.
English: • Insert the tip of the needle/non-vented transfer device into the center of the vial stopper and push straight downward.
Slovenian: • Uvedite konico igle/neprezračevanega pripomočka za prenos v sredino zamaška viale ter enakomerno potisnite.
English: • patients with a certain kind of blood cancer (chronic lymphocytic leukaemia) which leads to a lack of antibody production and recurrent infections when preventative antibiotics have failed.
Slovenian: • bolniki z določeno vrsto krvnega raka (kronično limfocitno levkemijo), ki povzroči pomanjkanje tvorbe protiteles in ponavljajoče se okužbe, ko je bilo preventivno antibiotično zdravljenje neuspešno,
English: How to use HyQvia
Slovenian: Kako uporabljati zdravilo HyQvia
English: You will be watched carefully throughout the infusion and for at least 1 hour after stopping the infusion to see how well you tolerate the medicine.
Slovenian: Med infundiranjem in še najmanj 1 uro po njem vas bodo natančno opazovali, da vidijo, kako prenašate zdravilo.
English: The other ingredients are sodium chloride, sodium phosphate, human albumin, ethylenediaminetetraacetic acid (EDTA) disodium, calcium chloride and water for injections (see also section 2, “HyQvia contains sodium”).
Slovenian: Druge sestavine so natrijev klorid, natrijev fosfat, humani albumin, dinatrijev edetat, kalcijev klorid in voda za injekcije (glejte tudi poglavje 2, ”Zdravilo HyQvia vsebuje natrij”).
English: • patients with a specific cancer of the bone marrow (multiple myeloma) and lack of antibody production with recurrent infections who have failed to respond to a vaccine against certain bacteria (pneumococci).
Slovenian: • bolniki s posebnim rakom kostnega mozga (multiplim mielomom) in pomanjkanjem tvorbe protiteles s ponavljajočimi se okužbami, ki se niso odzvali na cepivo proti določenim bakterijam (pnevmokokom),
English: Keep the vials in the outer carton in order to protect from light.
Slovenian: Viali shranjujte v zunanji ovojnini za zagotovitev zaščite pred svetlobo.
English: • Prepare to transfer the recombinant human hyaluronidase component of HyQvia by wiping each vial stopper with an alcohol swab, if directed and allow to air dry (at least 30 seconds).
Slovenian: • Komponento z rekombinantno humano hialuronidazo zdravila HyQvia na prenos pripravite tako, tako da obrišete zamašek vsake viale z alkoholnim tamponom, če je tako določeno, in pustite, da se posuši na zraku (vsaj 30 sekund).
English: Infusion for subcutaneous use.
Slovenian: Infuzija za subkutano uporabo.
English: 5.0 (3.3 to 5.1)
Slovenian: 5,0 (3,3 do 5,1)